Back to Results
First PageMeta Content
Genentech / Ranibizumab / Macular telangiectasia / Retina / Ophthalmology / Vision / Macular degeneration


FOR IMMEDIATE RELEASE Quinton Oswald Appointed Chief Executive Officer of Neurotech Pharmaceuticals Seasoned Executive Brings Wealth of Experience to Ophthalmic Biotechnology Pioneer, Including Leadership of SARcode Bio
Add to Reading List

Document Date: 2015-02-04 14:45:03

Open Document

File Size: 164,94 KB

Share Result on Facebook

Company

Novartis / Neurotech Pharmaceuticals Seasoned Executive Brings Wealth / QLT Inc. / SARcode Bioscience Inc. / AMD / Shire plc / Neurotech Pharmaceuticals Inc. / Genentech / /

Currency

USD / /

Event

M&A / FDA Phase / Employment Change / /

IndustryTerm

treatment of retinal diseases / biotechnology / leadingedge solutions / therapies for retinal disease / treatment of retinal disease / therapeutics for the treatment of chronic retinal diseases / /

MedicalCondition

glaucoma / protein drugs targeting uveitis / dry eye disease / retinal diseases / chronic retinal diseases / macular degeneration / retinal disease / Macular Telangiectasia / blindness / /

Organization

FDA / /

Person

Jim Mazzo / Ted / Quinton Oswald / /

Position

organization forward / CEO / Vice President & Business Unit Head / Executive Chairman / Chief Executive Officer / consultant / Chief Executive Officer / replacing Edward “Ted” Danse / Chief Executive Officer / replacing Edward “Ted” Danse / /

Product

Visudyne / Lucentis / Renexus® / /

Technology

antibodies / Biotechnology / /

URL

www.neurotechusa.com / /

SocialTag